Browsing Tag

Partnering

580 posts

J&J, US Gov’t Commit $1 Bn More To Develop J&J’s COVID-19 Vaccine
By

By
Johnson & Johnson (J&J) has expanded its partnership with the US government through a joint commitment from both parties to provide an additional $1 billion ($604 million from J&J and…

CureVac Finalizing EU Supply Pact for COVID-19 Vaccine; Expanding Mfg
By

By
CureVac, a Tubingen, Germany-based clinical-stage biopharmaceutical company developing messenger ribonucleic acid (mRNA) therapeutics, is finalizing an agreement with the European Commission (EC) to supply its COVID-19 vaccine, CVnCoV, and is…

Global Pharma Briefs: News from Biogen, Biocon, and bluebird bio
By

By
A roundup of news from India (Biocon) and the US (Biogen and bluebird bio). India Biocon Biologics OKs $150-M Capital Injection from Goldman SachsThe board of Biocon Biologics, a biosimilars…

Merck KGaA, Vera Therapeutics in $711-M Deal for Investigational Protein
By

By
Merck KGaA has taken a 10% equity stake and formed an out-licensing agreement with Vera Therapeutics, a San Francisco, California-based biopharmaceutical company, for the further development of Vera’s investigational therapy,…

Pharma COVID Roundup: News from J&J, Novavax, Regeneron, CureVac
By

By
The latest on manufacturing and potential treatments for COVID-19 with news from Johnson & Johnson, Novavax, Regeneron, CureVac, Aspen Pharmacare, and others. Manufacturing and supply of COVID-19 vaccines and drugs…

Global Pharma Briefs: News from Novartis, BMS, AstraZeneca
By

By
A roundup of news from Japan (Lilly, Daiichi Sankyo, Novartis), the UK (AstraZeneca, GSK), and the US (BMS, Novartis, Vedere Bio, Nostrum Laboratories). Japan Novartis Gets OK for CAR-T Cell…

Pharma COVID Roundup: News from Sanofi, GSK, Novartis, Takeda, BI
By

By
The latest on manufacturing and potential treatments for COVID-19 with news from Sanofi, GSK, Novartis, Takeda, BI, Moderna, Regeneron, and Novavax. Manufacturing and supply news for COVID-19 vaccines and drugs…

Lilly, US Gov’t Form $375-M Supply Pact for COVID-19 mAb Candidate
By

By
Eli Lilly and Company has entered into an agreement for $375 million with the US government to supply 300,000 vials of LY-CoV555 (bamlanivimab) (700 mg), the company’s investigational monoclonal antibody…

Pharma COVID Roundup: News from AstraZeneca, Moderna, J&J, BMS, AbbVie
By

By
The latest on manufacturing and potential treatments for COVID-19 with news from AstraZeneca, Moderna, Roche, J&J, BMS, AbbVie, Sanofi, Fujifilm, and others.  Manufacturing and supply news for COVID-19 vaccines and…

Pharma COVID Roundup: News from Lilly, Pfizer, AstraZeneca, Gilead
By

By
The latest on manufacturing and potential treatments for COVID-19 with news from Lilly, AbbVie, BI, Gilead Sciences, Pfizer, AstraZeneca, CSL, Takeda and others. Lilly Comments on COVID Trial Enrollment Pause…